Genes to clinic in an autoimmune disease
The JDRF/Wellcome Diabetes and Inflammation Laboratory at the Wellcome Centre for Human Genetics aims to identify and characterise type 1 diabetes risk regions of the human genome and use this information to identify disease mechanisms in order to target potential preventative and therapeutic strategies. Examples include enhancing immunomodulatory functions of the interleukin-2 pathway and preventing the loss of immune tolerance to insulin.
Date:
23 February 2018, 13:00 (Friday, 6th week, Hilary 2018)
Venue:
Sherrington Building, off Parks Road OX1 3PT
Venue Details:
Large Lecture Theatre
Speaker:
Professor John Todd (Wellcome Trust Centre for Human Genetics, University of Oxford)
Organising department:
Department of Physiology, Anatomy and Genetics (DPAG)
Organiser:
Sally Collins (University of Oxford)
Organiser contact email address:
hod-pa@dpag.ox.ac.uk
Hosts:
Dr James Cantley (Department of Physiology, Anatomy and Genetics),
Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
Part of:
DPAG Head of Department Seminar Series
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Sally Collins
